|Bid||0.8159 x 1100|
|Ask||0.0000 x 800|
|Day's range||0.8130 - 0.8485|
|52-week range||0.5500 - 7.5000|
|Beta (5Y monthly)||1.79|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2022 - 15 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||6.00|
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
LOS ANGELES & ATLANTA, March 10, 2022--COVID-19 investigational vaccine developed by City of Hope produced neutralizing antibodies and T cells with no major side effects in Phase 1 trial.